http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105503603-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_55d2d8989f1d88678e523954a877413e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C67-313
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-716
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C67-313
filingDate 2015-12-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e6d7cc0afcf466d528626c61da3bc04b
publicationDate 2016-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-105503603-A
titleOfInvention Method for synthesizing atropine drug intermediate acetonedicarboxylic acid
abstract A method for synthesizing an atropine drug intermediate acetonedicarboxylic acid includes the following steps that 2.8 mol of hypochlorous phenyl ester solution and 600 ml of sodium chloride solution are added into a reaction container provided with a stirrer, a thermometer and a dropping funnel, the solution temperature is reduced to 3-6 DEG C, stirring speed is controlled to be 110-160 rpm, 3.2-3.6 mol of 3-amino-3-amide-glutaric acid, 1.6 mol of alumina and 300 ml of dimethylbenzene are slowly added in batches, addition time is controlled to be 90-120 min, the solution temperature is slowly raised to 50-55 DEG C, reaction is conducted for 100-150 min, the solution temperature is reduced to 2-5 DEG C, standing is conducted for 3-5 h, 1200 ml of potassium bromide solution is added in the stirring state, white solid is separated out, subjected to suction filtration, washed with a saline solution and cyclohexanone, dehydrated with a dehydration agent and recrystallized in N-methylformamide, and crystal of acetonedicarboxylic acid is obtained.
priorityDate 2015-12-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2520
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7967
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24497
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419486329
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449731539
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453962614
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507591
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7237
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68328
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9989226
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID280800
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10129962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24538
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID174174
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451577746
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14797
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31254
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410697574
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID253877
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100685087
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25212
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412077482
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419489307
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454240270
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152743279
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419590337
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22921
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451818717
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25320
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID14459
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447827115
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413998695
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534806

Total number of triples: 47.